Associated Papers
Colony-stimulating factor 3 receptor (CSF3R) M696T mutation does not impact on clinical outcomes of a Ph+ acute lymphoblastic leukemia patient.
Chen X et al.
Blood Science (baltimore, Md.), 2021
Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series.
Scott AJ et al.
Familial Cancer, 2021
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.
Trottier AM et al.
Blood Advances, 2020
Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations.
Lance A et al.
Leukemia, 2020
Select a paper to view details